Q & A
Ask a question
There are no questions yet
🇬🇧 Michael (UK) — ordered Erlocip 100mg Tablet · 14 min ago
🇨🇦 Priya (Canada) — bulk enquiry · 38 min ago
🇦🇺 Order shipped to Melbourne — DHL Express tracked
🇫🇷 Laurent (France) — 4th repeat order confirmed ✓
🇸🇬 Bulk supply to Singapore clinic — 40 units confirmed
🇩🇪 Klaus (Germany) — enquiry for Erlocip 100mg Tablet
🇺🇸 Dr. Chen (USA) — hospital order confirmed
🇦🇪 Ahmad (UAE) — 5★ verified buyer
🇳🇱 Order to Netherlands · discreet pack
🇯🇵 Kenji (Japan) — export docs requested
🇬🇧 Michael (UK) — ordered Erlocip 100mg Tablet · 14 min ago
🇨🇦 Priya (Canada) — bulk enquiry · 38 min ago
🇦🇺 Order shipped to Melbourne — DHL Express tracked
🇫🇷 Laurent (France) — 4th repeat order confirmed ✓
🇸🇬 Bulk supply to Singapore clinic — 40 units confirmed
🇩🇪 Klaus (Germany) — enquiry for Erlocip 100mg Tablet
🇺🇸 Dr. Chen (USA) — hospital order confirmed
🇦🇪 Ahmad (UAE) — 5★ verified buyer
🇳🇱 Order to Netherlands · discreet pack
🇯🇵 Kenji (Japan) — export docs requested
🩺 Anti Cancer
Sale!
Erlocip 100mg Tablet
Manufactured by / Trademark: Cipla
54 viewing now
21 enquiries / 48 hrs
11 shipped / week
Our Price
$3,873
Global Retail
$5,959
Save $2,086 (35% off)
In Stock — Ships within 48 hrs
📦 Bulk discounts available — enquire for volume pricing
🔥 5 people ordered in the last 24 hours · Only 10 units remaining
Genuine Stock
Export Docs
Discreet Pack
Cold-Chain
🚚 Estimated Delivery to Your Country
🇬🇧🇩🇪🇫🇷
Europe
7–10 days
Express courier
🇺🇸🇨🇦🇦🇺
US / CA / AU
10–14 days
EMS / courier
🇦🇪🇸🇦🇯🇵
Middle East / Asia
5–8 days
Express courier
Trustpilot
★★★★★
Excellent
4.6 / 5
21 verified reviews
🔒 Secure Payment Options
SSL encrypted · All transactions are private & secure
Erlocip 100mg Tablet (Erlotinib) is an oral targeted therapy used for treating non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), effectively slowing down the growth and spread of cancer cells.
Erlocip 100mg Tablet contains Erlotinib, a selective oral tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR). This medication is primarily prescribed for patients with advanced non-small cell lung cancer (NSCLC) and pancreatic cancer. By blocking EGFR signaling, Erlotinib disrupts cancer cell proliferation, making it a vital component of modern cancer therapy.
Key Features:
- Contains Erlotinib, an effective oral targeted therapy
- Indicated for non-small cell lung cancer (NSCLC) and pancreatic cancer
- Inhibits the activity of EGFR to slow down tumor growth
- Convenient oral dosage form for improved patient adherence
- Often used in combination with other cancer treatment modalities
Frequently Ordered Together
View all →
Reviews
There are no reviews yet